Stress and self-efficacy predict psychological adjustment at diagnosis of prostate cancer

Curtis, Ruth; Groarke, AnnMarie; Sullivan, Frank

doi:10.1038/srep05569

Cited by 55 publications

(52 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…15,17 We were unable to confirm any strong association of other HPAA biomarkers and depression in this cohort of men; however, our results are similar to the previous results demonstrating the importance of stress in predicting psychological functioning in men with prostate cancer. 18 Moreover, the only predictor of physical QoL was group status. These specific results need to be considered with caution since the difference in physical QoL may be explained by the different disease stage and not the treatment received.…”

Section: Discussionmentioning

confidence: 99%

Biopsychosocial impact of prostate cancer and androgen-deprivation therapy

Tripp

Verreault²,

Tong

et al. 2017

CUAJ

View full text Add to dashboard Cite

Introduction: Prostate cancer is the most non-cutaneous malignancy in men, and androgen-deprivation therapy (ADT) is a cornerstone of management in advanced disease. The aim of this study was to evaluate the association of ADT with changes in depression and mental and physical quality of life (QoL) within a prospective patient cohort design. Methods: Patients were prospectively recruited and consented at a single academic health sciences centre in Ontario, Canada. Inclusion criteria included those men with adenocarcinoma of the prostate and either on watchful waiting or initiating ADT as palliation or as an adjuvant therapy for high-risk localized disease. All three cohorts were followed in routine care and completed psychosocial evaluations, including depression, social support, anxiety, and QoL measures. Results: In comparison to the control cohort of patients with prostate cancer on watchful waiting, initiation of ADT over a two-year period of time was not associated with any changes in depression or mental QoL. Instead, all patients, regardless of treatment cohort, showed increased depression scores and reduced mental QoL scores over time; however, for patients receiving ADT, a significant reduction in physical QoL compared to patients who did not receive ADT was demonstrated. Conclusions: ADT does not appear to significantly impact depressive symptoms and mental QoL over a two-year period; however, the depressive symptoms in this limited sample of men with prostate cancer was higher than expected and monitoring for these may be advisable for those who care for such patients. IntroductionProstate cancer is the most common non-cutaneous malignancy and the second leading cause of cancer-related death of men in North America.1 Androgen-deprivation therapy (ADT) remains a cornerstone of management of advanced disease; ADT improves survival when used in combination with radiotherapy in men with high-risk localized cancer, and represents standard palliation for men with incurable disease.2-4 Despite the cancer-related benefits, ADT has been well-shown to be associated with short-and long-term adverse effects, including sexual dysfunction, fatigue, hot flashes, osteoporosis, and cardiovascular complications.5 There is increasing evidence that ADT may also impact the psychological well-being of prostate cancer patients; 6,7 however, there are conflicting results in the literature as to the impact of ADT on depression. Many studies that have implicated ADT in depression either did not use validated depression-specific questionnaires or did not include control groups with patients suffering from prostate cancer and not receiving treatment. Thus, we sought to determine the impact of ADT on depression and mental and physical quality of life (QoL) in patients with both local and advanced disease using a prospective cohort study. We also wanted to determine the predictors of mental and physical QoL in men with prostate cancer. Methods ParticipantsParticipants were recruited from a single academic health sciences c...

show abstract

Section: Discussionmentioning

confidence: 99%

Biopsychosocial impact of prostate cancer and androgen-deprivation therapy

Tripp

Verreault²,

Tong

et al. 2017

CUAJ

View full text Add to dashboard Cite

show abstract

“…A dificuldade de adesão da população masculina ao exame de toque vem sendo constatada em diferentes estudos, em diversos contextos (Paiva et al, 2011;Krumwiede & Krumwiede, 2012;Curtis et al, 2013;Oliveira et al, 2014;King et al, 2015;Martins & Modena, 2016b). O momento da realização do exame de toque, também denominado pelos entrevistados como dedada, foi marcado por sentimentos de medo, vergonha e constrangimento e foi vivenciado como um procedimento muito invasivo e desconfortável.…”

Section: A Realização Dos Exames Preventivos Do Câncer Na Próstataunclassified

“…Além do incômodo físico, o procedimento desencadeia desconforto psicológico, no qual ao medo da descoberta de uma enfermidade grave se associa o receio de uma ereção durante o procedimento, gerando, assim, o temor de ser percebido pelo médico e pela equipe de saúde como um homossexual. Assim, a realização do exame de toque retal produz nos homens a sensação de redução de sua virilidade (Curtis et al, 2013;Martins et al, 2014;Modena et al, 2014;King et al, 2015;Martins & Modena, 2016b).…”

Section: A Realização Dos Exames Preventivos Do Câncer Na Próstataunclassified

“…O mesmo ocorre após a constatação do câncer, uma vez que os homens também apresentam dificuldades de aderir aos tratamentos propostos e de se adaptar à nova rotina de cuidados (Gomes, Nascimento, Rebello, & Araújo, 2008;Kelly, 2009;Gannon, GuerroBlanco, Patel, & Abel, 2010;Mesquita, Moreira, & Maliski, 2011;Paiva, Motta, & Griep, 2011;Burille, Schwartz, & Zillmer, 2013;Curtis, Groarke, & Sullivan, 2013;Martins & Modena, 2016a).…”

Section: Introductionunclassified

See 1 more Smart Citation

Representações Sociais De Corpo Após O Adoecimento Por Câncer Na Próstata

Martins¹,

Nascimento²

2017

Psicol Estud

View full text Add to dashboard Cite

RESUMO.O estudo tem como objetivo identificar e analisar as Representações Sociais de corpo para homens após o adoecimento por câncer na próstata. Foram realizadas entrevistas narrativas com oito homens com idade entre 50 e 70 anos, diagnosticados com câncer na p róstata e que realizaram tratamento oncológico há pelo menos um ano. As entrevistas foram gravadas, transcritas e analisadas por meio da Abordagem Fenomenológica Interpretativa. Os resultados apontam que antes do adoecimento, os participantes representavam seus corpos como fortes, resistentes e saudáveis, tendo no modelo de masculinidade hegemônica um importante ponto de ancoragem para estas representações. A ausência de sintomas que provocassem desconfortos corporais contribuiu para a percepção de corpo sa udável. A busca por serviços de saúde somente ocorreu após a manifestação e agravamentos dos primeiros sintomas, que limitaram suas ações diárias e alteraram o seu cotidiano. O adoecimento por câncer na próstata e as propostas de tratamento oncológico, em especial, a prostatectomia, foram destacados pelos participantes como uma experiência marcante e produtora de grande desconforto físico e psicológico. Após o adoecimento, os homens passaram a representar os seus corpos como frágeis, doentes e debilitados. Os entrevistados chamam a atenção para o impacto das transformações corporais, especialmente aquelas relacionadas às disfunções sexuais e urológicas, nos modos de pensar, sentir e agir, em relação à própria masculinidade. Nesse sentido, as limitações impos tas pelo adoecimento e tratamento oncológico se contrapõem ao modelo de masculinidade hegemônica, favorecendo o sentimento de ser menos homem do que antes do adoecimento. Palavras-chave:Câncer na próstata; masculinidade; representação social. SOCIAL REPRESENTATIONS OF THE BODY AFTER THE ILLNESS BY PROSTATE CANCERABSTRACT. This study aims to identify and analyze the social representations of body for men after the illness from prostate cancer. Narrative interviews were conducted with 08 men with age s ranging from 50 and 70 years, diagnosed with this disease and who had undergone oncological treatment, for at least one year. The interviews were recorded, transcribed and analyzed using the Interpretative Phenomenological Approach. The results show that before the illness, the participants represented their bodies as strong, resistant and healthy taking in the hegemonic masculinity model an important anchorage point for these representations. The absence of symptoms that cause bodily discomforts contribu ted to the feeling of healthy body. The search for health services only occurred after the manifestation of the first symptoms and its exacerbations, which limited their daily actions and change their daily lives. Participants mentioned the illness by prostate cancer and oncological treatment proposals, in particular the prostatectomy, as a remarkable experience that producer of great physical and psychological discomfort. After the illness, the men began to represent their bodies as fragile, sick a...

show abstract

“…[4] The most common psychological distresses in cancer patients include anxiety, depression, confusion, hostility, and anger. [5][6][7] However, the rate of depression is estimated to be four times higher than that of the other psychological distresses. [8] Based on prevalence studies, it is estimated that two in four to five cancer patients suffer from a major depressive episode after the time of diagnosis.…”

Section: Introductionmentioning

confidence: 99%

Depression screening in cancer patients: A narrative review

Abid

Kehyayan

Johnson

2018

JNEP

View full text Add to dashboard Cite

Depression is a significant and most common psychological symptom in cancer patients that causes a high risk of emotional and somatic consequences leading to poor quality of life. Despite the high prevalence of depression in cancer patients, the lack of screening and under-diagnosis of depression continues to be common. Numerous studies have shown that depression is a substantial complication in cancer patients that may lead to a variety of psychological and physical (somatic) symptoms. Presently, there are no depression screening practices at the Hamad Medical Corporation's (HMC) National Center for Cancer Care and Research (NCCCR), which is the principle public healthcare provider in the State of Qatar. The aim of this narrative review is to explore depression in cancer and discuss the need for screening for depression and to recommend suggestions and implications for future practice and research.

show abstract

Stress and self-efficacy predict psychological adjustment at diagnosis of prostate cancer

Cited by 55 publications

References 42 publications

Biopsychosocial impact of prostate cancer and androgen-deprivation therapy

Biopsychosocial impact of prostate cancer and androgen-deprivation therapy

Representações Sociais De Corpo Após O Adoecimento Por Câncer Na Próstata

Depression screening in cancer patients: A narrative review

Contact Info

Product

Resources

About